Pasi Korhonen is a seasoned professional specializing in biostatistics and real-world evidence, currently serving as Advisor Real World Evidence and Head of Data Solutions Business Unit at BCB Medical Ltd since October 2022. Korhonen is the Founder and Adjunct Professor of Biostatistics at Rewodat Oy, alongside a role as a private investor at ArtXperience Oy and Panacea CG Oy. With a rich history in leadership positions, including Senior Principal at IQVIA Nordics and Chief Scientific Officer at EPID Research, Korhonen has extensive experience in contract research, pharmacoepidemiologic studies, and clinical trials. Additionally, Korhonen has been an Adjunct Professor of Biostatistics at the University of Turku since 2009 and holds a PhD in Biostatistics from the University of Helsinki.